Baji, Petra; Péntek, Márta; Szántó, Sándor; … - In: The European Journal of Health Economics 15 (2014) 1, pp. 45-52
This is the first study which includes a biosimilar drug in the meta-analysis of biological treatments in AS. The results have proven the similar efficacy and safety profile of infliximab-biosimilar treatment compared to other biologicals. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2014